Skip to main content
Premium Trial:

Request an Annual Quote

In-Q-Tel Invests in Claremont to Accelerate Sample Prep Platform

NEW YORK (GenomeWeb News) – Claremont BioSolutions said today it has entered a strategic partnership with investment firm In-Q-Tel to accelerate commercialization of Claremont's Prep-on-a-Chip sample preparation platform.

The Upland, Calif.-based nucleic acid extraction and purification products firm added that In-Q-Tel also invested in the company but provided no further details.

Claremont is leveraging the mechanical energy of micromotors used in the cell phone industry to develop disposable sample prep devices that "efficiently lyse any cell type and simultaneously extract DNA or RNA." The devices are battery powered and are currently operated by hand. Use of a syringe or pipette transports the sample through a small chamber where the cells are lysed and nucleic acids are extracted in less than five minutes, Clarement said.

"The In-Q-Tel investment will aid us in our mission to multiplex and automate the handling of the devices, completing our development of the Prep-on-a-Chip platform," Claremont CEO Gary Blackburn said in a statement.

During the past year the company announced distribution deals covering Europe, Taiwan, South Korea, Japan, the UK, and Ireland.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.